Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Q2 2025 Astellas Pharma Inc Earnings Presentation Transcript

Oct 30, 2024 / NTS GMT
Release Date Price: $12 (+8.60%)
Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & IR Officer

Presentation
Oct 30, 2024 / NTS GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & IR Officer
* Naoki Okamura
Astellas Pharma Inc - President, Chief Executive Officer, Representative Director
* Claus Zieler
Astellas Pharma Inc - Chief Commercial Officer

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc. - Analyst
* Seiji Wakao
JPMorgan Securities Japan Co., Ltd - Analyst
* Shinichiro Muraoka
JPMorgan Securities Japan Co., Ltd - Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot